Bruno Fattizzo Raffaella Pasquale Valentina Bellani Wilma Barcellini Austin G Kulasekararaj
10.3389/fimmu.2021.791429
Front Immunol
2021 Nov 25;12:791429.
covid19 vaccine sars-cov-2 autoimmune hemolytic anemia cold agglutinin disease hemolytic uremic syndrome paroxysmal nocturnal hemoglobinuria
CC BY
https://pubmed.ncbi.nlm.nih.gov/34899761/
Anemia, Hemolytic, Autoimmune / immunology COVID-19 / immunology COVID-19 Vaccines / immunology Complement System Proteins / immunology Hemoglobinuria, Paroxysmal / immunology SARS-CoV-2 / immunology
Anemia, Hemolytic, Autoimmune / immunology COVID-19 / immunology COVID-19 Vaccines / immunology Complement System Proteins / immunology Hemoglobinuria, Paroxysmal / immunology SARS-CoV-2 / immunology Case Reports Review Adolescent Adult Aged Anemia, Hemolytic, Autoimmune / therapy COVID-19 / prevention & control COVID-19 / virology COVID-19 Vaccines / administration & dosage Complement Activation / drug effects Complement Activation / immunology Complement Inactivating Agents / therapeutic use Female Hemoglobinuria, Paroxysmal / therapy Humans Male Middle Aged SARS-CoV-2 / physiology COVID-19 Vaccines Complement Inactivating Agents Complement System Proteins
PMC8655106
34899761
Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
2021